van Oort IM - Search Results

1

An Update to the Pilot Study of ¹⁷⁷Lu-PSMA in Low Volume Hormone-Sensitive Prostate Cancer.

Privé BM, Muselaers CHJ, van Oort IM, Janssen MJR, Peters SMB, van Gemert WAM, Uijen MJM, Schilham MMG, Sedelaar JPM, Westdorp H, Mehra N, Gotthardt M, Barentsz JO, Gerritsen WR, Witjes JA, Nagarajah J. Privé BM, et al. Among authors: van oort im, van gemert wam. Front Nucl Med. 2022 May 3;2:863101. doi: 10.3389/fnume.2022.863101. eCollection 2022. Front Nucl Med. 2022. PMID: 39354959 Free PMC article.

2

Genetic correction of PSA values using sequence variants associated with PSA levels.

Gudmundsson J, Besenbacher S, Sulem P, Gudbjartsson DF, Olafsson I, Arinbjarnarson S, Agnarsson BA, Benediktsdottir KR, Isaksson HJ, Kostic JP, Gudjonsson SA, Stacey SN, Gylfason A, Sigurdsson A, Holm H, Bjornsdottir US, Eyjolfsson GI, Navarrete S, Fuertes F, Garcia-Prats MD, Polo E, Checherita IA, Jinga M, Badea P, Aben KK, Schalken JA, van Oort IM, Sweep FC, Helfand BT, Davis M, Donovan JL, Hamdy FC, Kristjansson K, Gulcher JR, Masson G, Kong A, Catalona WJ, Mayordomo JI, Geirsson G, Einarsson GV, Barkardottir RB, Jonsson E, Jinga V, Mates D, Kiemeney LA, Neal DE, Thorsteinsdottir U, Rafnar T, Stefansson K. Gudmundsson J, et al. Among authors: van oort im. Sci Transl Med. 2010 Dec 15;2(62):62ra92. doi: 10.1126/scitranslmed.3001513. Sci Transl Med. 2010. PMID: 21160077 Free PMC article.

3

Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomes.

Hendriks RJ, Dijkstra S, Jannink SA, Steffens MG, van Oort IM, Mulders PF, Schalken JA. Hendriks RJ, et al. Among authors: van oort im. Clin Chem Lab Med. 2016 Mar;54(3):483-92. doi: 10.1515/cclm-2015-0599. Clin Chem Lab Med. 2016. PMID: 26630694

4

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

Hessels D, Klein Gunnewiek JM, van Oort I, Karthaus HF, van Leenders GJ, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. Hessels D, et al. Eur Urol. 2003 Jul;44(1):8-15; discussion 15-6. doi: 10.1016/s0302-2838(03)00201-x. Eur Urol. 2003. PMID: 12814669

5

Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer?

van Oort IM, Schout BM, Kiemeney LA, Hulsbergen CA, Witjes JA. van Oort IM, et al. Eur Urol. 2005 Oct;48(4):572-6. doi: 10.1016/j.eururo.2005.06.003. Eur Urol. 2005. PMID: 16046051

6

The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study.

van Oort IM, Tomita K, van Bokhoven A, Bussemakers MJ, Kiemeney LA, Karthaus HF, Witjes JA, Schalken JA. van Oort IM, et al. Among authors: van bokhoven a. Prostate. 2007 Sep 15;67(13):1432-8. doi: 10.1002/pros.20626. Prostate. 2007. PMID: 17639504

7

Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer.

van Oort IM, Witjes JA, Kok DE, Kiemeney LA, Hulsbergen-vandeKaa CA. van Oort IM, et al. World J Urol. 2008 Jun;26(3):237-41. doi: 10.1007/s00345-008-0242-7. Epub 2008 Feb 12. World J Urol. 2008. PMID: 18265988 Free PMC article.

8

The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system.

van Oort IM, Witjes JA, Kok DE, Kiemeney LA, Hulsbergen-Van De Kaa CA. van Oort IM, et al. BJU Int. 2008 Aug;102(4):438-41. doi: 10.1111/j.1464-410X.2008.07611.x. Epub 2008 Mar 11. BJU Int. 2008. PMID: 18336608

9

A single institution experience with biochemical recurrence after radical prostatectomy for tumors that on pathology are of small volume or "insignificant".

van Oort IM, Kok DE, Kiemeney LA, Hulsbergen-van de Kaa CA, Witjes JA. van Oort IM, et al. Urol Oncol. 2009 Sep-Oct;27(5):509-13. doi: 10.1016/j.urolonc.2008.04.014. Epub 2008 Jul 14. Urol Oncol. 2009. PMID: 18625570

10

Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.

Hambrock T, Fütterer JJ, Huisman HJ, Hulsbergen-vandeKaa C, van Basten JP, van Oort I, Witjes JA, Barentsz JO. Hambrock T, et al. Invest Radiol. 2008 Oct;43(10):686-94. doi: 10.1097/RLI.0b013e31817d0506. Invest Radiol. 2008. PMID: 18791410

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters